Bogda Koczwara 🌻🌻🌻 (@bogda_koczwara) 's Twitter Profile
Bogda Koczwara 🌻🌻🌻

@bogda_koczwara

Mother, wife, runner | Oncologist researching #survivorship Director, Australian Research Centre for Cancer Survivorship |

ID: 746500198180892672

calendar_today25-06-2016 00:28:11

7,7K Tweet

3,3K Followers

1,1K Following

Chloe Lim (she/her) (@chloe_ys_lim) 's Twitter Profile Photo

Loved this thought-provoking pan-shop on the complex relationship between adolescent #mentalhealth, #technology, and #socialmedia. Young people use technology to foster relationships and build autonomy; we need to support them in this without judgement. #CAMH25 #CAMHC25 Australian & New Zealand Mental Health Association

Loved this thought-provoking pan-shop on the complex relationship between adolescent #mentalhealth, #technology, and #socialmedia. Young people use technology to foster relationships and build autonomy; we need to support them in this without judgement. #CAMH25 #CAMHC25 <a href="/anzmha/">Australian & New Zealand Mental Health Association</a>
Bogda Koczwara 🌻🌻🌻 (@bogda_koczwara) 's Twitter Profile Photo

April is Youth Cancer Awareness Month. Younger people face unique challenges when it comes to cancer that are often inadequately addressed. And the rates of early onset cancers are rising. But there is much to be done! And we can do it! Canteen Australia

April is Youth Cancer Awareness Month.

Younger people face unique challenges when it comes to cancer that are often inadequately addressed. And the rates of early onset cancers are rising.

But there is much to be done! And we can do it! <a href="/CanteenAus/">Canteen Australia</a>
Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42 Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… OncoAlert

Yakup Ergün (@dr_yakupergun) 's Twitter Profile Photo

Secondary malignancy risk after testicular GCT treatment 21 trials, 88,863 pts, mFU: 12.5y No ⬆️ risk with surgery alone ⬆️ risk with RT (1.66), chemo (1.65), or both (2.73) 💥Important to keep in mind when deciding treatment in stage 1 JNCI academic.oup.com/jnci/advance-a…

Secondary malignancy risk after testicular GCT treatment

21 trials, 88,863 pts, mFU: 12.5y

No ⬆️ risk with surgery alone

⬆️ risk with RT (1.66), chemo (1.65), or both (2.73)

💥Important to keep in mind when deciding treatment in stage 1

<a href="/JNCI_Now/">JNCI</a>

academic.oup.com/jnci/advance-a…
Oncology News Australia (@oncologynewsaus) 's Twitter Profile Photo

🎧 NEW PODCAST: No Longer Invisible – exploring #metastatic #cancer #survivorship with Bogda Koczwara 🌻🌻🌻 Nicolas Hart & Dr Andrea Smith Why we must rethink care for those living “in the place in between.” 🎙️Listen: t.ly/6ODFq #Cancer #SupportiveCare #MedEd #Podcast

🎧 NEW PODCAST: No Longer Invisible – exploring #metastatic #cancer #survivorship with <a href="/bogda_koczwara/">Bogda Koczwara 🌻🌻🌻</a> <a href="/DrNicolasHart/">Nicolas Hart</a> &amp; <a href="/DrAndreaLSmith/">Dr Andrea Smith</a>

Why we must rethink care for those living “in the place in between.”

🎙️Listen: t.ly/6ODFq
#Cancer #SupportiveCare #MedEd #Podcast
Ranjana Srivastava (@docranjana) 's Twitter Profile Photo

The cost of getting care and getting there: why is hospital parking so expensive in Australia? | Ranjana Srivastava | The Guardian theguardian.com/commentisfree/…

Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

#ASCO25 #plenary If the graph on the left is practice changing, the graph on the right is urgently practice changing. Cost to health systems-$15K to $18K a month vs $100-$150 a month. ATOMIC trial vs CHALLENGE trial.

#ASCO25 #plenary
If the graph on the left is practice changing, the graph on the right is urgently practice changing. 
Cost to health systems-$15K to $18K a month vs $100-$150 a month. 
ATOMIC trial vs CHALLENGE trial.
Nicolas Hart (@drnicolashart) 's Twitter Profile Photo

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival: “For every 16 people, exercise prevents 1 person from recurrent/new cancer” “For every 14 people, exercise prevents 1 person from dying”

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”
Prunella Blinman (@drprunellab) 's Twitter Profile Photo

Staggered this wasn’t a plenary at #asco25 ASCO OS benefit Minimal toxicity Cost effective Generalizable What a missed opportunity! Well done to all involved 👏

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Shocking data 🤯 Effect size is huge, way larger than expected Urgent to seek reproduction/validation of the finding in further studies, given the potential implications on clinical practice and clinical trials (across oncology fields)

Matt Spraker (@sprakermdphd) 's Twitter Profile Photo

Exercise may or may not "fight cancer", but don't lose sight of the big picture. Prospective studies show a lot of other benefits. These are generally high value for patients. Other benefits should be high value for healthcare decision makers too (ex. peri op outcomes)

Exercise may or may not "fight cancer", but don't lose sight of the big picture. 

Prospective studies show a lot of other benefits. 

These are generally high value for patients. 

Other benefits should be high value for healthcare decision makers too (ex. peri op outcomes)
Chad Han, AdvAPD, PhD (@chitchadkitchen) 's Twitter Profile Photo

Excited for tomorrow's #MASCC25 in Seattle! 🌲 This year's theme - INFORMED DECISIONS IN SUPPORTIVE CANCER CARE. Can’t wait to connect & collaborate! 🔗 mascc.org/annualmeeting2… #SupportiveCare #geriOnc #nutrition #GlobalOncology #AC2Project